Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. AAPS J. 2020 03 17; 22(3):59.
View in:
PubMed
subject areas
Adult
Aged
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Models, Statistical
Topoisomerase I Inhibitors
authors with profiles
Mark J. Ratain